Search

Search Constraints

You searched for: Author/Creator Deng, Maximilian

Search Results

1. Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma. Issue 7 (1st March 2021)

2. EPEN-15. Radiotherapy with helium ions has the potential to improve both endocrine and neurocognitive outcome in pediatric patients with ependymoma. (3rd June 2022)

3. Management of initial and recurrent radiation-induced contrast enhancements following radiotherapy for brain metastases: Clinical and radiological impact of bevacizumab and corticosteroids. (March 2023)

4. MBCL-08. INTEGRATIVE MOLECULAR ANALYSIS OF PATIENT-MATCHED DIAGNOSTIC AND RELAPSED MEDULLOBLASTOMAS. (4th December 2020)

5. MBRS-34. MOLECULAR CHARACTERIZATION OF RECURRENT MEDULLOBLASTOMA REVEALS AN UNEXPECTEDLY HIGH INCIDENCE OF SECONDARY MALIGNANCY. Issue 2 (22nd June 2018)

6. PATH-54. MULTI-DIMENSIONAL MOLECULAR CHARACTERIZATION OF PATIENT-MATCHED MEDULLOBLASTOMA AT DIAGNOSIS AND RELAPSE. (11th November 2019)

7. RADT-34. ANALYSIS OF A METHYLATION CLASS-GUIDED RADIOTHERAPY IN MENINGIOMA PATIENTS - AND THE PROSPECTIVE PHASE II MARCIE TRIAL WITH CARBON-ION BOOST RADIOTHERAPY. (14th November 2022)

8. RADT-40. RADIATION-INDUCED CONTRAST ENHANCEMENT FOLLOWING PROTON RADIOTHERAPY FOR LOW-GRADE GLIOMA DEPENDS ON TUMOR CHARACTERISTICS AND IS RARER IN CHILDREN THAN ADULTS. (14th November 2022)

9. RADT-41. IATROGENIC INFLUENCE ON PROGNOSIS OF RADIATION-INDUCED CONTRAST ENHANCEMENTS IN PATIENTS WITH GLIOMA WHO 1-3 FOLLOWING PHOTON AND PROTON RADIOTHERAPY. (14th November 2022)

10. To fly or not to fly: Stereotactic MR-guided adaptive radiotherapy effectively treats ultracentral lung tumors with favorable long-term outcomes. (May 2023)